Since the CSF core biomarkers have been incorporated to the current diagnostic criteria for AD for complementing clinical impression with biological support of AD pathology, the primary objective of this meta-review is to present an updated systematic and critical review on the diagnostic performance of the CSF core biomarkers for AD (Aβ42, T-tau, and p-tau). Here, MAPT is linked to Alzheimer disease.